Facts:
- Nasdaq Listing is to raise capital for the purpose of building the US business. FDA for Patch & OTC will come. Hygea represents a tiny miniscule fraction of what lies ahead. Existing revenues from Call Centres are at infancy stage. With approvals, GMV will establish agreements with health providers, insurance companies, and telco's. GMV will sell and lease its products, with the bulk of revenue coming from a recurring manner. This US business will be valued at more than $1B alone. Assuming a Price to Earning Ratio of 10:1 or 20:1 equates to $50m-$100m revenue per year. Achievable? Absolutely!
- HKSE Listing is to raise capital for the purpose of building the Chinese business. CFDA for Prizma & Patch to come. Oh, BTW we have Green Channel. The Chinese Government selected GMV to invest $5m into. Joint Venture to address serious Healthcare sector inefficiences. We'll raise a lazy $250m on the HK listing. No need to introduce the MOUs, we know what they are. But, remembering the size of the Chinese market, and the the many agreements we will sign for sales, leasing, and telehealth monitoring services, $500m is a very conservative target for revenue each year. Multiply that by 10 x PE Ratio. $5B.
- Europe CE Mark is not done for silly reasons. I expect to see a London Stock Exchange listing next year. Europe call centre ready. Agreements to come. Add similar numbers to the US Business.
Combined, we can reach $6-7B market cap in the next 3 years. Best thing is about to happen. Listing in new markets that value companies far better. ASX has a long way to go. Snapchat and Instagram didnt turnover a $1 until recently. Uber still making mass losses. Facebook same deal. Yet, they are worth $80B some of them. Even on the ASX some stocks are priced with 40-50x PE Ratios. Potential is the key word. Get used to it. Big moves about to happen for GMV. Hence I have loaded the truck at anything below $0.22. When HKSE listing is done, our SP will be worth an absolute minimum of $0.75. Come Xmas, minimum $1.50. All in my opinion.
- Forums
- ASX - By Stock
- GMV
- GMV The Future
GMV The Future, page-6
-
-
- There are more pages in this discussion • 3,008 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GMV (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online